Softwr

Research · head to head

Chemaxon vs Genedata

Chemaxon logo

Chemaxon

Research

Cheminformatics toolkits and structure handling, now a Certara subsidiary

From
On request
Rated
-
Full reviewWebsite
Genedata logo

Genedata

Research

Enterprise R&D data platforms for biologics, screening and bioprocess, owned by Danaher

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Chemaxon the October 2024 Certara acquisition ended two decades of vendor neutrality, and organisations that embedded JChem precisely because Chemaxon competed with nobody now depend on a component owned by a company that sells into their accounts.; Genedata there is no entry level and no published price at any tier, so a mid-sized biotech cannot even establish whether Genedata is in its range without a lengthy sales engagement.
  • They diverge on capability: Chemaxon covers Marvin, Genedata covers Screener.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which Chemaxon and Genedata actually diverge.

Attributes where Chemaxon and Genedata differ
AttributeChemaxonGenedata
PlatformsWeb, Windows, macOS, Linux, On-premise, APIWeb, On-premise, Private cloud

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Research).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Chemaxon

  • Marvin
  • JChem toolkits
  • Calculator Plugins
  • Compound Registration
  • Instant JChem
  • Design Hub
  • Free academic package
  • Embedded redistribution

Only in Genedata

  • Screener
  • Biologics
  • Bioprocess
  • Expressionist
  • Selector
  • Profiler
  • Instrument integration
  • GxP-capable deployments

What people use each for

The jobs each tool is most often brought in to do.

Chemaxon

  • A software vendor embedding a structure sketcher and search into its own product rather than writing chemistry codenot Genedata
  • A pharmaceutical informatics team building an internal compound registration system on JChem cartridgesnot Genedata
  • A computational chemistry group needing consistent pKa and logD prediction across a screening cascadenot Genedata
  • A university teaching cheminformatics that can use the free two-year academic package for a classnot Genedata

Genedata

  • A pharmaceutical screening group processing thousands of plates a week where manual QC and curve fitting no longer scalenot Chemaxon
  • A biologics discovery team linking antibody sequence, expression and assay data across a campaign instead of in spreadsheetsnot Chemaxon
  • A process development group standardising bioprocess run data across sites for modelling and scale-upnot Chemaxon
  • A CRO delivering high-throughput screening results to sponsors that require documented, reproducible analysis pipelinesnot Chemaxon

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Chemaxon

  • The October 2024 Certara acquisition ended two decades of vendor neutrality, and organisations that embedded JChem precisely because Chemaxon competed with nobody now depend on a component owned by a company that sells into their accounts.
  • Licensing is genuinely complicated, with different terms for named users, servers, desktop applications and embedded redistribution, so working out what you are allowed to deploy usually requires a conversation rather than reading a document.
  • The free academic package is granted for two-year terms and covers education rather than research, so a research group that assumed it was free discovers it needs a paid commercial academic licence.
  • Nothing is priced publicly for commercial use, so a team evaluating Chemaxon against open source alternatives such as RDKit cannot compare total cost without entering a sales process.
  • Open source cheminformatics has closed much of the functional gap for basic structure handling and search, so the commercial case increasingly rests on prediction quality, support and registration workflows rather than on capability that cannot be obtained elsewhere.

Genedata

  • There is no entry level and no published price at any tier, so a mid-sized biotech cannot even establish whether Genedata is in its range without a lengthy sales engagement.
  • Platforms are licensed individually and most organisations need two or three, so the real contract is a sum of separate licences plus the integration work between them.
  • Deployment is a services programme rather than an installation, running months and requiring scientific configuration by the vendor, which means value arrives long after the first invoice.
  • Danaher ownership since 2023 gives the roadmap a natural pull toward Danaher instrument and bioprocessing lines, which is an advantage on that hardware and a question to ask if your instrument estate is from competitors.
  • Validated deployments for regulated use add scope, cost and an ongoing revalidation obligation on your side after each vendor release, and that recurring internal effort is rarely counted in the business case.

Pricing, plan by plan

Chemaxon

On request
  • Academic package$undefined/year
    • Free of charge for education for a two-year term
    • Covers a class including tutor and students, or an applicant faculty
    • Non-commercial research use only
  • Commercial licence$undefined/year
    • Quoted per named user, per server or per redistributed application
    • Toolkits, desktop applications and embedded redistribution licensed separately
    • Annual support and maintenance included in the subscription

Genedata

On request
  • Genedata platform licence$undefined/year
    • Each platform, such as Screener or Biologics, licensed separately
    • Annual enterprise subscription scoped on users, sites and data volume
    • Implementation and scientific configuration services quoted as a separate programme

Which should you pick?

Choose Chemaxon if

  • You need marvin.
  • You work on Web, Windows, macOS, Linux, On-premise, API.
  • You also want jchem toolkits.
Chemaxon review

Choose Genedata if

  • You need screener.
  • You work on Web, On-premise, Private cloud.
  • You also want biologics.
Genedata review

Questions people ask

Is Chemaxon or Genedata better?
Neither clearly leads. Chemaxon starts at On request and Genedata at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Chemaxon or Genedata?
Chemaxon starts at On request and Genedata at On request.
Does Chemaxon or Genedata run on more platforms?
Chemaxon runs on Web, Windows, macOS, Linux, On-premise, API. Genedata runs on Web, On-premise, Private cloud.
What is Chemaxon best used for?
Chemaxon is most often used for a software vendor embedding a structure sketcher and search into its own product rather than writing chemistry code, a pharmaceutical informatics team building an internal compound registration system on jchem cartridges, a computational chemistry group needing consistent pka and logd prediction across a screening cascade, a university teaching cheminformatics that can use the free two-year academic package for a class. Of those, a software vendor embedding a structure sketcher and search into its own product rather than writing chemistry code and a pharmaceutical informatics team building an internal compound registration system on jchem cartridges are not what Genedata is typically brought in for.
What can Chemaxon do that Genedata cannot?
Chemaxon covers Marvin, JChem toolkits, Calculator Plugins, Compound Registration. Genedata covers Screener, Biologics, Bioprocess, Expressionist.

Answered from the vendors’ own pages

Chemaxon: Is Chemaxon still independent?

No. It has been a subsidiary of Certara since October 2024. The products continue under the Chemaxon name.

Genedata: Who owns Genedata?

Danaher acquired the company in 2023. It remains headquartered in Basel and continues under the Genedata name.

Chemaxon: Is the academic licence really free?

The education package is free for two-year terms covering a class or faculty. Non-commercial research groups pay a discounted commercial academic licence.

Genedata: Is there a small-team or starter option?

No. Everything is an enterprise contract scoped by users, sites and data volume, with services attached.

Chemaxon: Can I ship Chemaxon inside my own software?

Yes, but embedded redistribution is licensed separately from internal use and must be negotiated.

Genedata: Do I buy one product or the whole suite?

Each platform is licensed separately. Most customers license two or three and integrate between them.

Chemaxon: How does it compare with RDKit?

RDKit is free and covers basic structure handling well. Chemaxon differentiates on property prediction, registration workflows, the sketcher and commercial support.

Genedata: Can it be used in a GxP environment?

Yes, with a validated deployment contracted as additional scope. Ongoing revalidation after releases remains your responsibility.

Share

Related pages

More on Chemaxon

More on Genedata

Keep looking

Other head to heads